Chargement en cours...

Current approaches for optimizing the benefit of biologic therapy in ulcerative colitis

As biologic-based medication options for ulcerative colitis expand, our understanding of their optimal use in clinical practice is advancing as well. The appropriate use of combination therapy with immunomodulators can reduce the immunogenicity of biologic agents and raise serum drug levels of the b...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Therap Adv Gastroenterol
Auteurs principaux: Sofia, M. Anthony, Rubin, David T.
Format: Artigo
Langue:Inglês
Publié: SAGE Publications 2016
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4913335/
https://ncbi.nlm.nih.gov/pubmed/27366223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756283X16643242
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!